The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Discovery of farnesoid X receptor and its role in bile acid metabolism
Open accessAbstract
In 1995, the nuclear hormone orphan receptor farnesoid X receptor (FXR, NR1H4) was identified as a farnesol receptor expressed mainly in liver, kidney, and adrenal gland of rats. In 1999, bile acids were identified as endogenous FXR ligands. Subsequently, FXR target genes involved in the regulation of hepatic bile acid synthesis, secretion, and intestinal re-absorption were identified. FXR signaling was proposed as a mechanism of feedback regulation of the rate-limiting enzyme for bile acid synthesis, cholesterol 7α-hydroxylase (CYP7A1). The primary bile acids synthesized in the liver are transformed to secondary bile acids by the gut microbiota. The gut-to-liver axis plays a critical role in the regulation of bile acid synthesis, composition and circulating bile acid pool size, which in turn regulates glucose, lipid, and energy metabolism. Dysregulation of bile acid metabolism and FXR signaling in the gut-to-liver axis contributes to metabolic diseases including obesity, diabetes, and non-alcoholic fatty liver disease. This review will cover the discovery of FXR as a bile acid sensor in the regulation of bile acid metabolism and as a metabolic regulator of lipid, glucose, and energy homeostasis. It will also provide an update of FXR functions in the gut-to-liver axis and the drug therapies targeting bile acids and FXR for the treatment of liver metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
Kakiyama, G., Marques, D., Takei, H., Nittono, H., Erickson, S. K., Fuchs, M. A., Rodríguez‐Agudo, D., Gil, G., Hylemon, P. B., Zhou, H., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.011 · Cited by 48
Developmental expression of elements of hepatic cholesterol metabolism in the rat.
Smith, J. L., Lear, S. R., & Erickson, S. K. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40050-1 · Cited by 47
Cui, J., Heard, T. S., Yu, J., Lo, J., Huang, L., Li, Y., Schaeffer, J. M., & Wright, S. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200824200 · Cited by 46
Miao, J., Choi, S., Seok, S. M., Yang, L. C., Zuercher, W. J., Xu, Y., Willson, T. M., Xu, H. E., & Kemper, J. K. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0033 · Cited by 44
Modulation of Hepatocyte Apoptosis: Cross-talk Between Bile Acids and Nuclear Steroid Receptors
Publisher, B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521823 · Cited by 42
Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1
Fan, L., Joseph, J. F., Durairaj, P., Parr, M. K., & Bureik, M. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0379 · Cited by 38
Alkhouri, N., Tincopa, M. A., Loomba, R. S., & Harrison, S. A. (2021) · Hepatology Communications · doi:10.1002/hep4.1814 · Cited by 31
Yan, S., Khambu, B., Chen, X., Dong, Z., Guo, G. L., & Yin, X. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.10.011 · Cited by 27
FXR Agonists as Therapy for Liver Disease
Hoofnagle, J. H. (2020) · Hepatology · doi:10.1002/hep.31265 · Cited by 21
Marchianò, S., Biagioli, M., Roselli, R., Zampella, A., Giorgio, C. D., Bordoni, M., Bellini, R., Morretta, E., Monti, M. C., Distrutti, E., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101397r · Cited by 21
Mouzaki, M., & Loomba, R. S. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00290-2 · Cited by 8
Statins Show Promise Against Progression of Liver Disease
Francis, P., & Forman, L. (2021) · Clinical Liver Disease · doi:10.1002/cld.1143 · Cited by 6
Cited by
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
New insights into microbial bile salt hydrolases: from physiological roles to potential applications
Dong, Z., Yang, S., Tang, C., Li, D., Kan, Y., & Yao, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1513541 · Cited by 64
Azizsoltani, A., Niknam, B., Taghizadeh-Teymorloei, M., Ghoodjani, E., Dianat-Moghadam, H., & Alizadeh, E. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118249 · Cited by 15
Wang, Y., Bendre, S. V., Krauklis, S. A., Steelman, A. J., & Nelson, E. R. (2025) · Endocrinology · doi:10.1210/endocr/bqaf031 · Cited by 6
Metadata
- Authors
- Chiang, J. Y. L., & Ferrell, J. M.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 548
- Pages
- 111618
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W4221066727
- Cited by
- 288
- References
- 212
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.